Article

Fanged frogs cure cancer! You just wait... It could happen

Author(s):

Susan McClure

A friend of mine called me yesterday to tell me about an astonishing discovery. Forty new species, including fanged frogs, super-sized rats, and a grunting fish have been discovered in an extinct volcano in New Guinea. He was marveling at how cool our planet is while I was wondering to myself why these new discoveries couldn't include soft, cuddly new dog species. Maybe these discoveries were best left undiscovered. Then it dawned on me... What if the cure for cancer is contained in one of these new plant or animal discoveries? Could fanged frogs save us all? Many of cancer's most innovative treatments have been derived from plants, sea creatures, etc... Don't believe me? Check out our Summer 2006 cover story "Surf & Turf: Nature's Hidden Medicines." To read more about the 40 new species, go to www.guardian.co.uk/environment/2009/sep/07/discovery-species-papua-new-guinea

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of women with text.
Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Related Content
Image of Linda Cohen.
July 14th 2025

Finding Freedom and Uncertainty in My Cancer Remission Pause

Linda Cohen
I’m in remission from small lymphocytic lymphoma and off treatment, savoring this break while learning to live with the uncertainty that still lingers.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
July 14th 2025

The Power of Suggestion in Breast Cancer Prevention

Bonnie Annis
A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
A A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma: © stock.adobe.com.
July 14th 2025

Real-World Data Supports Amtagvi’s Benefit in Advanced Melanoma

Spencer Feldman
A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma, supporting earlier use after immunotherapy.
Image of Andy.
July 13th 2025

Finding Comfort and Connection in the Chemo Lounge

Andy Winnegar
During treatment for chronic lymphocytic leukemia and autoimmune anemia, I found relief and encouragement in a caring conversation with my oncology nurse.